Sian writes about emerging start-up companies and new research from academia. She is especially interested in the pet health space, as well as the introduction of digital technology for both companion animals and livestock. She also has an interest in increasing Animal Pharm's equine coverage, as she owns horses herself.
In addition to covering animal health news and conducting interviews with worldwide companies, Sian also works on the evolving Animal Pharm Product Approvals Index.
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Latest From Sian Lazell
Zomedica Pharmaceuticals has recorded a higher net loss in the first quarter of 2018, as it builds out the company and continues investing in R&D.
Australian firm Anatara Lifesciences has highlighted the key financial aspects of its recent agreement for Detach with Zoetis,
Merck Animal Health has launched a next generation line of influenza vaccines for horses.
According to one expert, Zoetis' acquisition of Abaxis will aid the latter in competing against veterinary diagnostics leader IDEXX Laboratories.
The World Veterinary Association (WVA) and Ceva Santé Animale have underlined the growing focus on animal wellbeing by revealing the winners of the 2nd WVA Animal Welfare Awards.
Australian firm Anatara Lifesciences has announced its executive chairman Mel Bridges will be retiring.